CenterPoint Energy, Inc. is a holding company, which engages in the business of power generation and distribution. It operates through the following segments: Electric, Corporate and Other, and Natural Gas. The Electric segment includes electric transmission and distribution services. The Corporate and Other segment refers to the energy performance contracting and sustainable infrastructure services. The Natural Gas segment is involved in the sales of intrastate natural gas, permanent pipeline connections, and home appliance maintenance and repair services. The company was founded in 1866 and is headquartered in Houston, TX.
Ascendis Pharma has submitted a New Drug Application to the FDA for TransCon CNP (navepegritide), a once-weekly treatment for children with achondroplasia that demonstrated benefits beyond linear growth.
New clinical data reveals VOXZOGO (vosoritide) significantly reduces tibial bowing in children with achondroplasia, addressing a common cause of pain and functional impairment that often requires surgical intervention.